Modulation of Multiple Sclerosis and its Animal Model experimental Autoimmune encephalomyelitis by Food and Gut Microbiota

Ward J. van den Hoogen, Jon D. Laman*, Bert A. 't Hart

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

61 Citations (Scopus)
487 Downloads (Pure)

Abstract

Multiple sclerosis (MS) is an autoimmune neurological disease characterized by chronic inflammation of the central nervous system (CNS), leading to demyelination, axonal damage, and symptoms such as fatigue and disability. Although the cause of MS is not known, the infiltration of peripherally activated immune cells into the CNS has a key pathogenic role. Accumulating evidence supports an important role of diet and gut microbiota in immune-mediated diseases. Preclinical as well as clinical studies suggest a role for gut microbiota and dietary components in MS. Here, we review these recent studies on gut microbiota and dietary interventions in MS and its animal model experimental autoimmune encephalomyelitis. We also propose directions for future research.

Original languageEnglish
Article number1081
Number of pages24
JournalFrontiers in Immunology
Volume8
DOIs
Publication statusPublished - 5-Sept-2017

Keywords

  • prebiotic
  • probiotic
  • autoimmunity
  • immunomodulation
  • fecal transplant
  • Food
  • gut microbiome
  • CENTRAL-NERVOUS-SYSTEM
  • EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
  • REGULATORY T-CELLS
  • POLYUNSATURATED FATTY-ACIDS
  • ADMINISTERED LACTOBACILLUS STRAINS
  • ARYL-HYDROCARBON RECEPTOR
  • CNS DEMYELINATING DISEASE
  • PATHOGENIC T(H)17 CELLS
  • VITAMIN-D
  • BACTERIAL PEPTIDOGLYCAN

Fingerprint

Dive into the research topics of 'Modulation of Multiple Sclerosis and its Animal Model experimental Autoimmune encephalomyelitis by Food and Gut Microbiota'. Together they form a unique fingerprint.

Cite this